Diligence memo · auto-generated · as of July 2, 2026
Zaina Pharma Inc.
Zaina Pharma Inc. looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Zaina Pharma Inc. operates in Pharmaceuticals, based in LARGO.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Zaina Pharma Inc. has raised $250K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $250K on 2010-07-28.
Most recent recorded round closed around 2010-07-28.
Valuation (modeled)modeled
Provath models Zaina Pharma Inc. at approximately $12M (range $140K–$134M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.62× the median modeled value of Pre-Seed Pharmaceuticals companies in 2010–2012 (71 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 15.9 yr ago; this sector typically re-raises about every 13 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 6% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 20% of those peers.
Closest niche peers: Dermal Life, LLC, Armgo Pharma Inc, Third Day Healing Holdings LLC, Dermamedics Llc, China Yongxin Pharmaceuticals Inc..
Peoplefiled
3 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.